Carbohydrate Metabolism, Inborn Errors D002239

Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Metabolism, Inborn Errors » Carbohydrate Metabolism, Inborn Errors

Description

Dysfunctions of CARBOHYDRATE METABOLISM resulting from inborn genetic mutations that are inherited or acquired in utero.   MeSH

Hierarchy View

Subtype Terms (13)

Congenital Disorders of Glycosylation
6 drugs (2 approved, 4 experimental)

Fructose Metabolism, Inborn Errors
 

Fucosidosis
11 drugs (8 approved, 3 experimental)

Galactosemias
4 drugs (3 approved, 1 experimental)

Glucosephosphate Dehydrogenase Deficiency
11 drugs (5 approved, 6 experimental)

Glycogen Storage Disease
6 drugs (2 approved, 4 experimental)

Hyperoxaluria, Primary
6 drugs (2 approved, 4 experimental)

Lactose Intolerance
16 drugs (1 approved, 15 experimental)

Mannosidase Deficiency Diseases
5 drugs (4 approved, 1 experimental)

Mucolipidoses
7 drugs (6 approved, 1 experimental)


Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 3 Indications (1)

Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.